CellAegis Devices, Inc. Company Profile
CellAegis Devices, Inc., based in Toronto, Canada, is poised for EU market introduction in parallel with a broad international clinical testing program of the Companyâs proprietary, automated, noninvasive autoRIC⢠Device for Remote Ischemic Conditioning (RIC). Placed around the arm, CellAegisâ autoRIC Device allows for the first time, simple, consistent, reliable and cost-effective automation of RIC at the point of care, including acute care applications in the ambulance, emergency room and other hospital settings, or for chronic treatment in the home. The autoRIC Device is highly portable and time-efficient, delivering four cycles of simple-to-administer treatment in less than 40 minutes. The device is compatible with current standard-of-care treatments.
News Articles
AMTAC grants CE mark to CellAegis autoRIC device
AMTAC Certification Services has granted CE mark for CellAegis Devices's autoRIC device.
CellAegis Devices to use autoRIC Device for Chronic Remote Ischemic Conditioning
CellAegis Devices, Inc., announced today that it has received an Investigational Testing Approval from Health Canada that allows the initiation of clinical testing in Canada of the Company's autoRIC D...
CellAegis wins Canadian approval for remote ischemic conditioning device
CellAegis Devices has obtained Health Canada's marketing authorization for its proprietary, automated, noninvasive device autoRIC device for remote ischemic conditioning (RIC).
Health Canada grants ITA approval to CellAegis to begin autoRIC device trial
CellAegis Devices has obtained Health Canada's investigational testing (ITA) approval to initiate a pilot clinical trial of its noninvasive autoRIC device for remote ischemic conditioning (RIC).
CellAegis gets CE mark for remote ischemic conditioning device
CellAegis has earned CE mark approval to market its autoRIC device in Europe. -More-
CellAegis Devices Receives CE Mark for autoRIC™ Device in the European Union
CellAegis Devices, Inc., announced today that it has received a CE Mark for the Company’s autoRIC™ Device, which for the first time allows simple, consistent, reliable and cos...
CellAegis Devices, Inc., announced today the first clinical program to evaluate the use of the Company’s autoRIC™ Device for remote ischemic conditioning (RIC) in patients wit...
TORONTO, May 2, 2013 /PRNewswire/ -- CellAegis Devices, Inc., announced today the first clinical trial program in the European Union to evaluate the use of the Company's autoRIC™ Device for Chro...
Drugs and Medications
Alcohol [Dalian Rongbang Medical Helathy Devices Co]
Alcohol Swabsticks
Alcohol prep pad [Dalian Rongbang Medical Healthy Devices]
Alcohol Prep Pad
Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A 750 ml
Povidone iodine [Dalian Rongbang Medical Healthy Devices Co]
Povidone Iodine Pad
Drug Facts
PubMed Articles
How medical devices are regulated in the UK.
Excluding medicines, most other healthcare products are medical devices.1 It is estimated that around 38 million people in the UK "have contact with" a medical device every day,2 and there are more th...
An all-gas-phase approach for the fabrication of silicon nanocrystal light-emitting devices.
We present an all-gas-phase approach for fabrication of nanocrystal-based light-emitting devices. In a single reactor, silicon nanocrystals are synthesized, surface-functionalized, and deposited onto...
Micromolding of solvent resistant microfluidic devices.
We demonstrate a rapid fabrication procedure for solvent-resistant microfluidic devices based on the perfluoropolyether (PFPE) SIFEL. We carefully modified the poly-dimethylsiloxane (PDMS) micromoldin...
The Schottky-junction structure has been broadly applied in inorganic photovoltaic devices but has not yet been successfully applied in organic photovoltaic devices. Jinsong Huang and co-workers repor...
High throughput method for prototyping three-dimensional, paper-based microfluidic devices.
This paper describes an efficient and high throughput method for fabricating three-dimensional (3D) paper-based microfluidic devices. The method avoids tedious alignment and assembly steps and elimina...
Clinical Trials
This research includes the evaluation of a checklist and on-site screening devices to pre-select drivers suspected of being drug-impaired. The reliability of a limited number of promising...
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
The rise of minimal access surgery has heralded the approval of a number of endovascular devices with similar indications. This is particularly true for the treatment of lower extremity is...
The main hypothesis are: 1. Passive and Active-Passive airway conditioning devices reduce the incidence of ventilator associated pneumonia 2. Active-Passive airway conditi...
In-home health monitoring devices have the potential to increase the speed and ease of modifying treatment for ambulatory patients living with chronic conditions. This study examines the i...
Laryngeal Mask Supreme™ Versus the I-Gel™
We evaluate two new developed airway devices, which provide patent airway during general anesthesia. In 60 patients undergoing elective general anesthesia, we will simulate a difficult air...
Companies
CellAegis Devices, Inc., based in Toronto, Canada, is poised for EU market introduction in parallel with a broad international clinical testing program of the Companyâs propr...
Innovation, performance, and excellence are the cultural pillars on which Analog Devices has built one of the longest standing, highest growth companies within the technology sect...
CEA Technologies, Inc. is a contract designer and manufacturer of custom medical devices. These devices, either disposable or reusable, provide the vital connection from any type of electronic box to...
Symphonix Devices Incorporated
Hearing Devices.
Headquartered in Austin, Texas, Patton Medical Devices is the manufacturer of the i-port(R) Injection Port. For people taking injections who want to minimize the intrusion of injections on daily life,...
More Information about "CellAegis Devices, Inc." on BioPortfolio
We have published hundreds of CellAegis Devices, Inc. news stories on BioPortfolio along with dozens of CellAegis Devices, Inc. Clinical Trials and PubMed Articles about CellAegis Devices, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CellAegis Devices, Inc. Companies in our database. You can also find out about relevant CellAegis Devices, Inc. Drugs and Medications on this site too.
